- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06799403
Stop for Stress - a Randomized Controlled Trial Comparing an Online and a Group-based Format of an Intervention for Work-related Stress
June 13, 2025 updated by: Lea Nørgaard Sørensen
Stop for Stress - En Sammenligning af Online og Gruppebaseret Behandling for Arbejdsrelateret Stress
Work-related stress is a major public health concern, causing sickness absenteeism and impaired health and well-being.
Many afflicted with severe work-related stress will not receive evidence-based treatment due to geographical distance, stigma and unwillingness to participate in a group, creating unequality access to healthcare services.
Online interventions show comparable effects to face-to-face interventions and have potential to break down some of these barriers.
We have developed and pilot tested the online delivery format of the intervention for work-related stress, Stop for Stress, with promising results.
In a two-armed, multicentre randomized controlled trial we aim to 1) compare the effect of the online delivery format and an evidence-based face-to-face group-based format and 2) identify markers of enhanced outcomes in each delivery format.
The study will include 220 patients with severe work-related stress (110 from each of two centres) who are randomizes 1:1 to the two interventions.
Outcomes consist of self-report measures of psychological symptoms, cognitive functioning, sleep, and perceived working environment and register data on ebsenteeism and return-to-work.
Study Overview
Status
Recruiting
Conditions
Study Type
Interventional
Enrollment (Estimated)
220
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Lea N Sørensen, MSc Psychology
- Phone Number: +45 61369464
- Email: leanso@rm.dk
Study Contact Backup
- Name: Zara A Stokholm, MD, PhD
- Phone Number: +45 61369464
- Email: zarastok@rm.dk
Study Locations
-
-
Central Region Denmark
-
Aarhus, Central Region Denmark, Denmark, 8200
- Recruiting
- Department of Occupational and Environmental Medicine, Aarhus University Hospital
-
Contact:
- Lea N Sørensen, MSc Psychology
- Phone Number: +45 61369464
- Email: leanso@rm.dk
-
Contact:
- Zara A Stokholm, MD, PhD
- Phone Number: +45 61369464
- Email: zarastok@rm.dk
-
Herning, Central Region Denmark, Denmark, 7400
- Not yet recruiting
- Department of Occupational and Environmental Medicine, Gødstrup Hospital
-
Contact:
- Marianne Kyndi, MD, PhD
- Phone Number: +45 20949919
- Email: marianne.kyndi@rm.dk
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Current employment and significant work-related stressors
- Perceived Stress Scale (PSS-10) score ≥20 and symptom duration >4 weeks
- In case of full-time sick leave, return to work must be planned concurrent with the intervention
- Access to a computer or tablet with internet connection at home
Exclusion Criteria:
- Interpersonal difficulties, bullying, harassment, violence, threats, and traumatic events as primary stressor
- Severe stressors outside of work
- Symptoms meeting diagnostic criteria for anxiety, depression or severe psychiatric illnesses requiring specialized treatment
- Current abuse of alcohol and/or psychoactive drugs
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Therapist-assisted online delivery format
Participants will gain access to an online program comprised by 14 modules covering psychoeducation on stress, sleep, and communication, cognitive behavioral restructuring, and exercises and tools for dealing with stress and preventing relapse.
Participants are followed by a therapist providing feedback on exercises and progress.
The program extends over approx.
12 weeks.
|
Participants gain access to an online program comprised by 14 modules covering psychoeducation on stress, sleep, and communication, cognitive behavioral restructuring, and exercises and tools for dealing with stress and preventing relapse.
Participants are followed by a therapist providing feedback on exercises and progress.
The program extends over approx.
12 weeks.
Other Names:
|
|
Active Comparator: Group-based face-to-face delivery format
The group-based format consists of 8 sessions of each 3 hours spread across 12 weeks.
The sessions cover psychoeducation on stress, sleep, and communication, cognitive behavioral restructuring, and exercises and tools for dealing with stress and preventing relaps.
A group includes 8-9 participants
|
The group-based format consists of 8 sessions of each 3 hours spread across 12 weeks.
The sessions cover psychoeducation on stress, sleep, and communication, cognitive behavioral restructuring, and exercises and tools for dealing with stress and preventing relaps.
A group includes 8-9 participants
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Return-to-work
Time Frame: Participants are followed continously from 5 yeras prior to enrollment (baseline) and until 12 months follow-up
|
Derived from the Danish national DREAM registry, comprising information on weekly transfer income (e.g.
long-term sickness absence) and employment status
|
Participants are followed continously from 5 yeras prior to enrollment (baseline) and until 12 months follow-up
|
|
Perceived stress (T1)
Time Frame: Post intervention: 3 months from baseline
|
Self-report measure using the 10 item Perceived Stress Scale (PSS-10), 10 items on a 0-4 scale, ranging from 0-40 point with higher scores indicating more perceived stress.
|
Post intervention: 3 months from baseline
|
|
Obejctive cognitive functioning measures by ICAT (T2)
Time Frame: Follow-up: 6 months from baseline
|
ICAT (Internet-Based Cognitive Assessment Tool) comprises 5 subtests (list learning, consonant repitition, letter-number sequencing, delayed list learning, visuomotor tracking)
|
Follow-up: 6 months from baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Working environment (T1)
Time Frame: Post intervention: 3 months from baseline
|
Perceived working environment self-reported using selected (independent) items from the Danish Psychosocial Questionnaire (DPQ).
Includes influence, predictability, work load, relations to coworkers, relations to managers, recognition, and meaning.
|
Post intervention: 3 months from baseline
|
|
Working environment (T2)
Time Frame: Follow-up: 6 months from baseline
|
Perceived working environment self-reported using selected (independent) items from the Danish Psychosocial Questionnaire (DPQ).
Includes influence, predictability, work load, relations to coworkers, relations to managers, recognition, and meaning.
|
Follow-up: 6 months from baseline
|
|
Perceived Stress (T2)
Time Frame: Follow-up: 6 months from baseline
|
Self-report measure using the 10 item Perceived Stress Scale (PSS-10), 10 items on a 0-4 scale, ranging from 0-40 point with higher scores indicating more perceived stress.
|
Follow-up: 6 months from baseline
|
|
Perceived Stress (T3)
Time Frame: Follow-up: 12 months from baseline
|
Self-report measure using the 10 item Perceived Stress Scale (PSS-10), 10 items on a 0-4 scale, ranging from 0-40 point with higher scores indicating more perceived stress.
|
Follow-up: 12 months from baseline
|
|
Cognitive functioning (T1)
Time Frame: Post intervention: 3 months from baseline
|
Self-report measure using the Cognitive Failures Questionnaire (CFQ), 25 items on a 0-4 point scale, range 0-100 with higher scores indicating lower subjective cognitive functioning.
|
Post intervention: 3 months from baseline
|
|
Work ability (T1)
Time Frame: Post intervention: 3 months from baseline
|
Self-report measure using the Work Ability Index (WAI), 1 item scale ranging from 0-10 with higher scores indicating better work ability
|
Post intervention: 3 months from baseline
|
|
Work ability (T2)
Time Frame: Follow-up: 6 months from baseline
|
Self-report measure using the Work Ability Index (WAI), 1 item scale ranging from 0-10 with higher scores indicating better work ability
|
Follow-up: 6 months from baseline
|
|
Work ability (T3)
Time Frame: Follow-up: 12 months from baseline
|
Self-report measure using the Work Ability Index (WAI), 1 item scale ranging from 0-10 with higher scores indicating better work ability
|
Follow-up: 12 months from baseline
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Working environment (T3)
Time Frame: Follow-up: 12 months from baseline
|
Perceived working environment self-reported using selected (independent) items from the Danish Psychosocial Questionnaire (DPQ).
Includes influence, predictability, work load, relations to coworkers, relations to managers, recognition, and meaning.
|
Follow-up: 12 months from baseline
|
|
Utilizations of psychotropic drug prescriptions
Time Frame: Participants are followed continously from 5 yeras prior to enrollment (baseline) and until 12 months follow-up
|
Derived from the Danish national Register of Medical Products Statistics.
Includes presciptions on antidepressants, anxiolytics, sedatives and anagesics.
|
Participants are followed continously from 5 yeras prior to enrollment (baseline) and until 12 months follow-up
|
|
Sleep quality (T1)
Time Frame: Post intervention: 3 months from baseline
|
Self-report measure using the Basic Nordic Sleep Questionnaire (BSNQ), 7 items on a 1-5 scale, ranging from 7-35 points with higher scores indicating lower subjective sleep quality
|
Post intervention: 3 months from baseline
|
|
Sleep quality (T2)
Time Frame: Follow-up: 6 months from baseline
|
Self-report measure using the Basic Nordic Sleep Questionnaire (BSNQ), 7 items on a 1-5 scale, ranging from 7-35 points with higher scores indicating lower subjective sleep quality
|
Follow-up: 6 months from baseline
|
|
Sleep quality (T3)
Time Frame: Follow-up: 12 months from baseline
|
Self-report measure using the Basic Nordic Sleep Questionnaire (BSNQ), 7 items on a 1-5 scale, ranging from 7-35 points with higher scores indicating lower subjective sleep quality
|
Follow-up: 12 months from baseline
|
|
Symptoms of depression and anxiety (T1)
Time Frame: Post intervention: 3 months from baseline
|
Self-report measure using the Common Mental Disorders Questionniare (CMDQ), 10 items in total: 4 item on the anxiety scale (0-4 point scale, range 0-16) and 6 items on the depression scale (0-4 point scale, range 0-24) with higher scores indicating more severe symptoms.
|
Post intervention: 3 months from baseline
|
|
Symptoms of depression and axiety (T2)
Time Frame: Follow-up: 6 months from baseline
|
Self-report measure using the Common Mental Disorders Questionniare (CMDQ), 10 items in total: 4 item on the anxiety scale (0-4 point scale, range 0-16) and 6 items on the depression scale (0-4 point scale, range 0-24) with higher scores indicating more severe symptoms.
|
Follow-up: 6 months from baseline
|
|
Symptoms of depression and anxiety (T3)
Time Frame: Follow-up: 12 months from baseline
|
Self-report measure using the Common Mental Disorders Questionniare (CMDQ), 10 items in total: 4 item on the anxiety scale (0-4 point scale, range 0-16) and 6 items on the depression scale (0-4 point scale, range 0-24) with higher scores indicating more severe symptoms.
|
Follow-up: 12 months from baseline
|
|
Cognitive functioning (T2)
Time Frame: Follow-up: 6 months from baseline
|
Self-reportmeasure using the Cognitive Failures Questionnaire (CFQ), 25 items on a 0-4 point scale, range 0-100 with higher scores indicating lower subjective cognitive functioning.
|
Follow-up: 6 months from baseline
|
|
Cognitive functioning (T3)
Time Frame: Follow-up: 12 months from baseline
|
Self-reportmeasure using the Cognitive Failures Questionnaire (CFQ), 25 items on a 0-4 point scale, range 0-100 with higher scores indicating lower subjective cognitive functioning.
|
Follow-up: 12 months from baseline
|
|
Daily functioning (T1)
Time Frame: Post intervention: 3 months from baseline
|
Self-report measure using the Work and Social Adjustment Scale (WSAS), 5 items 0-8 point scale, ranging from 0-40 point, where higher scores indicate more impaired daily functioning.
|
Post intervention: 3 months from baseline
|
|
Daily functioning (T2)
Time Frame: Follow-up: 6 months from baseline
|
Self-report measure using the Work and Social Adjustment Scale (WSAS), 5 items 0-8 point scale, ranging from 0-40 point, where higher scores indicate more impaired daily functioning.
|
Follow-up: 6 months from baseline
|
|
Daily functioning (T3)
Time Frame: Follow-up: 12 months from baseline
|
Self-report measure using the Work and Social Adjustment Scale (WSAS), 5 items 0-8 point scale, ranging from 0-40 point, where higher scores indicate more impaired daily functioning.
|
Follow-up: 12 months from baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Zara A Stokholm, MD, PhD, Department of Occupational and Environmental Medicine, Danish Ramazzini Centre, Aarhus University Hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 27, 2025
Primary Completion (Estimated)
January 1, 2027
Study Completion (Estimated)
August 1, 2027
Study Registration Dates
First Submitted
January 23, 2025
First Submitted That Met QC Criteria
January 23, 2025
First Posted (Actual)
January 29, 2025
Study Record Updates
Last Update Posted (Actual)
June 17, 2025
Last Update Submitted That Met QC Criteria
June 13, 2025
Last Verified
June 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1-10-72-108-24
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Work-Related Stress
-
Universidad Europea de ValenciaCompletedWork-Related Condition | Work-Related Stress DisorderSpain
-
Work Life HelpNational Institute on Aging (NIA)CompletedPsychosocial Deprivation | Work-Related Stress | Life-work ImbalanceUnited States
-
Fundació Institut de Recerca de l'Hospital de la...Active, not recruitingWork-Related StressSpain
-
ARCIM Institute Academic Research in Complementary...CompletedBurnout | Work-Related StressGermany
-
University Hospital, Clermont-FerrandCompletedWork-Related Condition | Work-Related StressFrance
-
Team Working Life DenmarkNational Research Centre for the Working Environment, Denmark; Bispebjerg Hospital and other collaboratorsActive, not recruiting
-
National Research Centre for the Working Environment...TrygFonden, Denmark; Aalborg University; Team Arbejdsliv; Statistics DenmarkActive, not recruitingMusculoskeletal Pain | Occupational Exposure | Occupation-related Stress Disorder | Work-Related Stress Disorder | Work Accident | Work Injury | Work Related Upper Limb DisorderDenmark
-
Aarhus University HospitalUniversity of Aarhus; Bispebjerg Hospital; Herning HospitalActive, not recruitingWork Related Stress | Mental Health Issue | Work-related IllnessDenmark
-
XRWorkout, IncUniversity of Mississippi Medical CenterCompletedPhysical Inactivity | Work-Related Stress | Psychological Well-BeingUnited States
-
Sabine HahnUniversity of Applied Sciences and Arts of Southern Switzerland; University...CompletedStress | Work-Related Condition | Health Care Professionals
Clinical Trials on Therapist-assisted online stress management
-
Laval UniversityMinistère de la Justice, QuébecActive, not recruitingPost Traumatic Stress Disorder | Major Depressive Disorder | Insomnia DisorderCanada
-
Icahn School of Medicine at Mount SinaiNational Institute for Occupational Safety and Health (NIOSH/CDC)CompletedPost-Traumatic Stress DisorderUnited States
-
Celal Bayar UniversityCompletedAbused WomenTurkey (Türkiye)
-
Amasya UniversityCompletedThe Effect of Online Stress Management Program on Nurses' Individual Workload Perception, and StressStress | Nursing | Stress ManagementTurkey (Türkiye)
-
University Hospital, Basel, SwitzerlandSwiss National Science Foundation; Krebsforschung Schweiz, Bern, SwitzerlandCompletedCancer | Psychological DistressSwitzerland
-
University of FloridaCompleted
-
University of SfaxNot yet recruitingAnxiety Depression (Mild or Not Persistent)Tunisia
-
Boston IVFWithdrawnInfertilityUnited States
-
Washington State UniversityUnknownAnxiety Disorders and Symptoms | Cortisol | Perceived Stress | Executive Functioning | Stress Prevention | Depression Disorders and Symptoms | Motivation and Learning | Momentary Emotion | Study Strategies | Animal Behavior | Animal Stress | Dyadic Interaction | Alpha-amylaseUnited States
-
Oregon Center for Applied Science, Inc.Completed